ABT-202
 | |
| 識別資訊 | |
|---|---|
| |
| CAS號 | 309959-34-0  [NIH] |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| 化學資訊 | |
| 化學式 | C9H13N3 |
| 摩爾質量 | 163.219 |
| 3D模型（JSmol） | |
| |
| |
ABT-202是一種含氮有機化合物，分子式C9H13N3，由美國雅培公司開發，可作為煙鹼型乙酰膽鹼受體的激動劑，未經過臨床試驗。[1][2][3]
參考文獻
- ^ Jain KK. Modulators of nicotinic acetylcholine receptors as analgesics. Current Opinion in Investigational Drugs. January 2004, 5 (1): 76–81. PMID 14983978.
- ^ Romanelli MN, Gratteri P, Guandalini L, Martini E, Bonaccini C, Gualtieri F. Central nicotinic receptors: structure, function, ligands, and therapeutic potential. ChemMedChem. June 2007, 2 (6): 746–67. PMID 17295372. S2CID 34763474. doi:10.1002/cmdc.200600207.
- ^ Xu N, Kim GE, Gregg H, Wagdy A, Swaine BA, Chang MS, El-Shourbagy TA. Automated 96-well liquid-liquid back extraction liquid chromatography-tandem mass spectrometry method for the determination of ABT-202 in human plasma. Journal of Pharmaceutical and Biomedical Analysis. September 2004, 36 (1): 189–95. PMID 15351065. doi:10.1016/j.jpba.2004.05.013.